Cargando…
Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue‐specific drug binding, transport, and metabolism
Vinblastine (VBL) is a vinca alkaloid‐class cytotoxic chemotherapeutic that causes microtubule disruption and is typically used to treat hematologic malignancies. VBL is characterized by a narrow therapeutic index, with key dose‐limiting toxicities being myelosuppression and neurotoxicity. Pharmacok...
Autores principales: | Witta, Sandra, Collins, Keagan P., Ramirez, Dominique A., Mannheimer, Joshua D., Wittenburg, Luke A., Gustafson, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834611/ https://www.ncbi.nlm.nih.gov/pubmed/36631976 http://dx.doi.org/10.1002/prp2.1052 |
Ejemplares similares
-
In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease
por: Fitzpatrick, Rikki L., et al.
Publicado: (2018) -
Tolerability of a rapid‐escalation vinblastine‐prednisolone protocol in dogs with mast cell tumours
por: Serra Varela, Juan Carlos, et al.
Publicado: (2016) -
Vinblastine in the treatment of Hodgkin's disease.
por: Jelliffe, A. M.
Publicado: (1969) -
Inhibition of interferon secretion by vinblastine
por: Havell, EA, et al.
Publicado: (1975) -
Vinblastine-induced Acral Hyperpigmentation
por: Chakraborti, Annesha, et al.
Publicado: (2020)